Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cognitive, Disability, and Treatment Outcome Implications of Symptom-Based Phenotyping in Late-Life Depression

American Journal of Geriatric Psychiatry(2023)10.1016/j.jagp.2023.06.003Source: DataRank Database

Cognitive, Disability, and Treatment Outcome Implications of Symptom-Based Phenotyping in Late-Life Depression is a research paper published in American Journal of Geriatric Psychiatry (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.32)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Catherine Conway,Sarah M. Szymkowicz ORCID,Damian Elson,Hakmook Kang ORCID,Warren D. Taylor ORCID

Live enrichment

PubMed:37385899 PMC:PMC10592463 OpenAlex:https://openalex.org/W4380743053

National Institute of Mental Health

Grant: R01 MH102246

National Institute of Mental Health

Grant: R01 MH121620

National Institute of Mental Health

Grant: R01 MH123662

National Institute of Mental Health

Grant: UL1 TR000445

National Institutes of Health

National Center for Advancing Translational Sciences

FWCI

1.32

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10592463/pdf/nihms-1915117.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1064748123003317?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1064748123003317?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10592463

Fields of Study

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Research Topics

MeSH Terms

EscitalopramAgedCognitionDepressionFatigueHumansSleep Initiation and Maintenance DisordersCitalopramTreatment OutcomeAnhedonia

Keywords

EscitalopramRuminationWorryApathyAnhedoniaPlaceboPsychiatryClinical psychologyPsychologyRandomized controlled trialDepression (economics)Late life depressionSeverity of illnessMedicineAnxietyCognitionAntidepressantInternal medicineSchizophrenia (object-oriented programming)AgingDepressionGeriatricDisabilityClinical TrialAntidepressant Response

Sustainable Development Goals

SDG 0: No poverty